| South Arkansas Physician Services Llc | |
|
700 W Grove St El Dorado AR 71730-4416 | |
| (870) 863-2000 | |
| Not Available |
| Full Name | South Arkansas Physician Services Llc |
|---|---|
| Speciality | Family Medicine |
| Location | 700 W Grove St, El Dorado, Arkansas |
| Authorized Official Name and Position | Jennifer L Jackson (SR. DIRECTOR PROVIDER ENROLLMENT) |
| Authorized Official Contact | 8778929815 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| South Arkansas Physician Services Llc 7100 Commerce Way Suite 180 Brentwood TN 37027-2829 Ph: (615) 465-7000 | South Arkansas Physician Services Llc 700 W Grove St El Dorado AR 71730-4416 Ph: (870) 863-2000 |
| NPI Number | 1427018704 |
|---|---|
| Provider Enumeration Date | 03/23/2006 |
| Last Update Date | 03/05/2022 |
| Medicare PECOS PAC ID | 0749273670 |
|---|---|
| Medicare Enrollment ID | O20040406001623 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427018704 | NPI | - | NPPES |
| 145507002 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| 207R00000X | Internal Medicine | (* (Not Available)) | Secondary |
| 363L00000X | Nurse Practitioner | (* (Not Available)) | Secondary |
| Provider Name | Martha G Garrett Shaver |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1740274448 PECOS PAC ID: 8527971159 Enrollment ID: I20031110000677 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Althea T Conley |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1114995198 PECOS PAC ID: 7517851413 Enrollment ID: I20040819000963 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Rebecca A Luper |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1548245608 PECOS PAC ID: 6608841531 Enrollment ID: I20040901001374 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Benjamin M Dodge |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1922090471 PECOS PAC ID: 9436197175 Enrollment ID: I20050421001512 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Donald Voelker |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1548292386 PECOS PAC ID: 9931173879 Enrollment ID: I20060914000651 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Joseph A Deluca |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1417969478 PECOS PAC ID: 9335146844 Enrollment ID: I20061025000752 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Robert C Tommey |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1669467361 PECOS PAC ID: 4284730490 Enrollment ID: I20080716000469 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Teresa Mcdonald |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1700058245 PECOS PAC ID: 9436343910 Enrollment ID: I20101028000704 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Julie N Wylie |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1932377256 PECOS PAC ID: 1456546803 Enrollment ID: I20101110001208 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Angela Norman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1174613962 PECOS PAC ID: 4587851381 Enrollment ID: I20101206000978 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Harvinder S Dod |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1699983635 PECOS PAC ID: 0042292047 Enrollment ID: I20110210000034 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Albert O Obiozo |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1932476132 PECOS PAC ID: 1254587249 Enrollment ID: I20120807000511 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Venkata Spb Durvasula |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1770861478 PECOS PAC ID: 2567608573 Enrollment ID: I20130418000006 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Chelsea R Mansfield |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1669658837 PECOS PAC ID: 6901980796 Enrollment ID: I20140609001815 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Alero Nanna |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1588898761 PECOS PAC ID: 1254552409 Enrollment ID: I20141031001779 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Sharon M Tomaski |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1275605206 PECOS PAC ID: 3971586280 Enrollment ID: I20151022002017 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Anthony Milard Abraham |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1336474535 PECOS PAC ID: 1052563384 Enrollment ID: I20151210001785 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Oluwakunle Oluwatosin |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1396912796 PECOS PAC ID: 1557439262 Enrollment ID: I20151210002095 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Lensey C Scott |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1225126626 PECOS PAC ID: 7416082797 Enrollment ID: I20151223000334 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Edward Evans |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1083799985 PECOS PAC ID: 7012815046 Enrollment ID: I20151228000276 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Lashonda Evetta Traylor |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1306245345 PECOS PAC ID: 8426034331 Enrollment ID: I20160527000212 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Vivian Chioma Okoye |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1194067769 PECOS PAC ID: 9133415581 Enrollment ID: I20160910000159 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Stephanie M Dunn |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1578000287 PECOS PAC ID: 2062796170 Enrollment ID: I20170308001223 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Ashley Nicole Burns |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1003355488 PECOS PAC ID: 2769768100 Enrollment ID: I20170419000786 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Peggy Wren |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1225560162 PECOS PAC ID: 0446528517 Enrollment ID: I20170613002164 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Eliyahu Hemo |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1255627824 PECOS PAC ID: 7517277627 Enrollment ID: I20170819000026 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | James Albert Johnson |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1053378257 PECOS PAC ID: 8325001662 Enrollment ID: I20180124000791 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Christopher John Riley |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1366785222 PECOS PAC ID: 3678866217 Enrollment ID: I20180927001604 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Gabriel T Faz |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1285936625 PECOS PAC ID: 1850682477 Enrollment ID: I20190408001869 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Umberto Gaetano Fontana |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1033111315 PECOS PAC ID: 0749326601 Enrollment ID: I20190729001088 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Jessica Daigle |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1922397413 PECOS PAC ID: 3375849003 Enrollment ID: I20190813003030 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Fahad Javed |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1033425087 PECOS PAC ID: 2668641317 Enrollment ID: I20191106001575 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Carlos Anaya |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1538120860 PECOS PAC ID: 1254474448 Enrollment ID: I20200203000253 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Irfan Qureshi |
|---|---|
| Provider Type | Practitioner - Critical Care (intensivists) |
| Provider Identifiers | NPI Number: 1881853133 PECOS PAC ID: 5799006508 Enrollment ID: I20200623000221 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Abdul M Keylani |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1386692689 PECOS PAC ID: 5890755433 Enrollment ID: I20201016001514 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Samuel Agnew |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1952374498 PECOS PAC ID: 0547151318 Enrollment ID: I20210208000044 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
| Provider Name | Thomas Kennedy |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1396273173 PECOS PAC ID: 2567712904 Enrollment ID: I20220729000032 |
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
News Archive
A new study by Italian researchers and published online on the preprint server bioRxiv* in June 2020 reports the ability of several existing steroidal drugs to reduce the binding of the SARS-CoV-2 to the ACE2 receptor. This could help define newer strategies using viral entry blockers to reduce viral load.
I'm Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.
A BBC News article and related video examine the eastern Democratic Republic of Congo's battle with malaria. "'Malaria is the main killer here in Congo, especially for pregnant women and children,' says Dr. Vincker Lushombo, from Save the Children," BBC writes.
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters' expansion as more customers approach late-stage clinical development and commercialization.
Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.
› Verified 9 days ago
The Hannah Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 101 W Main St, Suite 201, El Dorado, AR 71730 Phone: 870-862-1317 Fax: 870-862-4297 | |
Uams Health Primary Care Center - El Dorado Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 620 W Grove St Ste 202, El Dorado, AR 71730 Phone: 870-234-7676 Fax: 870-562-2560 | |
Cabun Rural Health Services, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 601 Dr. Mlk Jr. Blvd, El Dorado, AR 71730 Phone: 870-639-3875 Fax: 870-798-4100 | |
Remel Buslig Md Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 818 Doe Meadow Ln, El Dorado, AR 71730 Phone: 870-864-0913 Fax: 870-864-0913 | |
William L. Harper, M.d., P.a. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 425 W Oak St, El Dorado, AR 71730 Phone: 870-863-5135 Fax: 870-863-5137 | |
Greg Smart Family Practice Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 209 Thompson Ave, El Dorado, AR 71730 Phone: 870-864-0333 Fax: 870-864-0336 | |
South Arkansas Physician Group Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 620 W Grove St Ste 202, El Dorado, AR 71730 Phone: 870-863-2000 |